Literature DB >> 30496437

Diminished B-Cell Response After Repeat Influenza Vaccination.

Mrinmoy Sanyal1,2,3, Tyson H Holmes1, Holden T Maecker4, Randy A Albrecht5,6, Cornelia L Dekker7, Xiao-Song He1,3, Harry B Greenberg1,4,3.   

Abstract

Annual vaccination with influenza vaccines is recommended for protection against influenza in the United States. Past clinical studies and meta-analysis, however, have reported conflicting results on the benefits of annual vaccination. B-cell responses elicited following repeat influenza vaccinations over multiple seasons have not been examined in detail. We analyzed the B-cell and antibody (Ab) responses in volunteers vaccinated yearly, from 2010 or 2011 through 2014, with seasonal trivalent inactivated influenza vaccines. Statistical analyses were designed to help correct for possible bias due to reduced sample size in the later years of the study. We show that, after the second annual vaccination, the frequency of vaccine-specific plasmablasts and the binding reactivity of plasmablast-derived polyclonal Abs are reduced and do not increase in subsequent years. Similar trends are observed with the serum hemagglutination inhibition Ab response after each annual vaccination, as well as the binding reactivity of plasmablast-derived polyclonal Abs to the hemagglutinin of influenza A virus vaccine components, even with changes in the seasonal vaccine components during the study. Our findings indicate a diminished B-cell response to annual vaccination with seasonal trivalent influenza vaccine. These results emphasize the need for developing improved strategies to enhance the immunogenicity and efficacy of annual influenza vaccination.
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  B-cell response; Influenza virus infection; antibody; influenza vaccine; plasmablast; repeated vaccination

Mesh:

Substances:

Year:  2019        PMID: 30496437      PMCID: PMC6473172          DOI: 10.1093/infdis/jiy685

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  37 in total

1.  Variable efficacy of repeated annual influenza vaccination.

Authors:  D J Smith; S Forrest; D H Ackley; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility.

Authors:  Suzanne E Ohmit; Joshua G Petrie; Ryan E Malosh; Alicia M Fry; Mark G Thompson; Arnold S Monto
Journal:  J Infect Dis       Date:  2014-11-21       Impact factor: 5.226

Review 3.  Immunosenescence: Influenza vaccination and the elderly.

Authors:  Kamran Haq; Janet E McElhaney
Journal:  Curr Opin Immunol       Date:  2014-04-25       Impact factor: 7.486

4.  High preexisting serological antibody levels correlate with diversification of the influenza vaccine response.

Authors:  Sarah F Andrews; Kaval Kaur; Noel T Pauli; Min Huang; Yunping Huang; Patrick C Wilson
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

5.  Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.

Authors:  Arnold S Monto; Joshua G Petrie; Rachel T Cross; Emileigh Johnson; Merry Liu; Weimin Zhong; Min Levine; Jacqueline M Katz; Suzanne E Ohmit
Journal:  J Infect Dis       Date:  2015-04-08       Impact factor: 5.226

6.  Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.

Authors:  Sanae Sasaki; Maria C Jaimes; Tyson H Holmes; Cornelia L Dekker; Kutubuddin Mahmood; George W Kemble; Ann M Arvin; Harry B Greenberg
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

7.  Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution.

Authors:  Björn F Koel; David F Burke; Theo M Bestebroer; Stefan van der Vliet; Gerben C M Zondag; Gaby Vervaet; Eugene Skepner; Nicola S Lewis; Monique I J Spronken; Colin A Russell; Mikhail Y Eropkin; Aeron C Hurt; Ian G Barr; Jan C de Jong; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier; Derek J Smith
Journal:  Science       Date:  2013-11-22       Impact factor: 47.728

8.  Antibody recognition of a highly conserved influenza virus epitope.

Authors:  Damian C Ekiert; Gira Bhabha; Marc-André Elsliger; Robert H E Friesen; Mandy Jongeneelen; Mark Throsby; Jaap Goudsmit; Ian A Wilson
Journal:  Science       Date:  2009-02-26       Impact factor: 47.728

9.  Heterovariant cross-reactive B-cell responses induced by the 2009 pandemic influenza virus A subtype H1N1 vaccine.

Authors:  Xiao-Song He; Sanae Sasaki; Jane Baer; Surender Khurana; Hana Golding; John J Treanor; David J Topham; Mark Y Sangster; Hong Jin; Cornelia L Dekker; Kanta Subbarao; Harry B Greenberg
Journal:  J Infect Dis       Date:  2012-10-29       Impact factor: 5.226

10.  A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season.

Authors:  Danuta M Skowronski; Catharine Chambers; Suzana Sabaiduc; Gaston De Serres; Anne-Luise Winter; James A Dickinson; Mel Krajden; Jonathan B Gubbay; Steven J Drews; Christine Martineau; Alireza Eshaghi; Trijntje L Kwindt; Nathalie Bastien; Yan Li
Journal:  Clin Infect Dis       Date:  2016-03-29       Impact factor: 9.079

View more
  10 in total

1.  Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes.

Authors:  Bo Ryoung Park; Jeeva Subbiah; Ki-Hye Kim; Young-Man Kwon; Judy Oh; Min-Chul Kim; Chong-Hyun Shin; Baik Lin Seong; Sang-Moo Kang
Journal:  Virology       Date:  2021-12-10       Impact factor: 3.616

Review 2.  Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines.

Authors:  Claudia Maria Trombetta; Otfried Kistner; Emanuele Montomoli; Simonetta Viviani; Serena Marchi
Journal:  Vaccines (Basel)       Date:  2022-05-01

Review 3.  Challenges of Making Effective Influenza Vaccines.

Authors:  Sigrid Gouma; Elizabeth M Anderson; Scott E Hensley
Journal:  Annu Rev Virol       Date:  2020-05-11       Impact factor: 10.431

4.  Kinetics of antibody response to influenza vaccination in renal transplant recipients.

Authors:  Shivaprakash Gangappa; Jens Wrammert; David Wang; Zhu-Nan Li; Justine S Liepkalns; Weiping Cao; Jufu Chen; Min Z Levine; James Stevens; Suryaprakash Sambhara; Beth Begley; Aneesh Mehta; Thomas C Pearson; Rafi Ahmed; Christian P Larsen
Journal:  Transpl Immunol       Date:  2019-01-18       Impact factor: 1.708

5.  Functional and Binding H1N1pdm09-Specific Antibody Responses in Occasionally and Repeatedly Vaccinated Healthcare Workers: A Five-Year Study (2009-2014).

Authors:  Håkon Amdam; Anders Madsen; Fan Zhou; Amit Bansal; Mai-Chi Trieu; Rebecca Jane Cox
Journal:  Front Immunol       Date:  2021-12-06       Impact factor: 7.561

6.  SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals.

Authors:  Kaori Sano; Disha Bhavsar; Gagandeep Singh; Daniel Floda; Komal Srivastava; Charles Gleason; Juan Manuel Carreño; Viviana Simon; Florian Krammer
Journal:  Nat Commun       Date:  2022-09-01       Impact factor: 17.694

7.  Effectiveness of the quadrivalent inactivated influenza vaccine in Japan during the 2015-2016 season: A test-negative case-control study comparing the results by real time PCR, virus isolation.

Authors:  Irina Chon; Reiko Saito; Akinobu Hibino; Ren Yagami; Clyde Dapat; Takashi Odagiri; Hiroki Kondo; Isamu Sato; Shinji Kimura; Takashi Kawashima; Naoki Kodo; Hironori Masaki; Norichika Asoh; Yoshiko Tsuchihashi; Hassan Zaraket; Yugo Shobugawa
Journal:  Vaccine X       Date:  2019-01-29

8.  The Effects of Imprinting and Repeated Seasonal Influenza Vaccination on Adaptive Immunity after Influenza Vaccination.

Authors:  Amy C Sherman; Lilin Lai; Mary Bower; Muktha S Natrajan; Christopher Huerta; Vinit Karmali; Jennifer Kleinhenz; Yongxian Xu; Nadine Rouphael; Mark J Mulligan
Journal:  Vaccines (Basel)       Date:  2020-11-07

9.  Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers.

Authors:  Lena Hansen; Fan Zhou; Håkon Amdam; Mai-Chi Trieu; Rebecca Jane Cox
Journal:  Front Immunol       Date:  2021-10-14       Impact factor: 7.561

10.  Opposing Effects of Prior Infection versus Prior Vaccination on Vaccine Immunogenicity against Influenza A(H3N2) Viruses.

Authors:  Annette Fox; Louise Carolan; Vivian Leung; Hoang Vu Mai Phuong; Arseniy Khvorov; Maria Auladell; Yeu-Yang Tseng; Pham Quang Thai; Ian Barr; Kanta Subbarao; Le Thi Quynh Mai; H Rogier van Doorn; Sheena G Sullivan
Journal:  Viruses       Date:  2022-02-25       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.